This established PCR based amplicon length differentiation assay (PCR-ALDA) was further validated and evaluated with other available assays for their diagnostic performance in a cohort of Vietnamese patients with MPN devoid of JAK2 V617F mutation. Here, JAK2 is linked to myeloproliferative disorder.